TransUnion (TRU) Reports Q2 EPS of $0.09

TransUnion (NYSE: TRU) reported Q2 EPS of $0.09, versus ($0.02) reported last year. Revenue for the quarter came in at $426 million, versus $378.5 million reported last year.

16 Full Year Outlook

For the full year of 2016, we are raising our revenue, Adjusted EBITDA and Adjusted Diluted Earnings per Share guidance as follows. Consolidated revenue is expected to be between $1.665 billion and $1.675 billion, an increase of approximately 12 percent on a constant currency basis. Adjusted EBITDA is expected to be between $613 million and $618 million, an increase of approximately 18 to 19 percent on a constant currency basis. Adjusted EBITDA margin is expected to be approximately 37 percent, an increase of approximately 200 basis points. Adjusted Diluted Earnings per Share is expected to be between $1.37 and $1.39, an increase of 25 to 27 percent.

This guidance includes approximately 2 percent revenue growth from acquisitions as well as approximately 1.5 percent declines in revenue and Adjusted EBITDA due to foreign exchange rates.

2016 Third Quarter Outlook

For the third quarter of 2016, consolidated revenue is expected to be between $420 million and $425 million, an increase of approximately 9 to 10 percent on a constant currency basis compared with the third quarter of 2015. Adjusted EBITDA is expected to be between $155 million and $158 million, an increase of approximately 11 to 13 percent on a constant currency basis. Adjusted Diluted Earnings per Share is expected to be between $0.34 and $0.35, an increase of approximately 12 to 15 percent.

This guidance includes approximately 2 percent revenue growth from acquisitions as well as approximately 1 percent declines in revenue and Adjusted EBITDA due to foreign exchange rates.

For earnings history and earnings-related data on TransUnion (TRU) click here.

You May Also Be Interested In

• BuzzFeed (BZFD) Misses Q1 EPS by 53c, Revenue Misses; Offers Weak Q2 Guidance
• Augmedix, Inc. (AUGX) Tops Q1 EPS by 1c, provides guidance
• Sanara MedTech Inc. (SMTI) Reports Q1 Loss of $0.21